Sonecon

Sonecon is an economic and strategic advisory firm that provides analysis and policy guidance to senior officials in the U.S. and foreign governments, as well as leaders of multinational corporations and non-profit organizations. While not a biotechnology or pharmaceutical developer itself, the firm is highly influential in the life sciences sector through its extensive research on the economic value of pharmaceutical innovation and the impact of healthcare policy. Led by Dr. Robert J. Shapiro, Sonecon frequently publishes high-profile reports analyzing the economic contributions of the biopharmaceutical industry and the potential consequences of drug pricing legislation. Their work serves as a key resource for industry trade groups and policymakers evaluating the intersection of economics, intellectual property, and medical advancement.